Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Castaigne

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|September 21, 1990
[Therapeutical trials in arterial hypertension in 1990]J P Castaigne
Contraception, Fertilite, Sexualite|January 1, 1985
[Triella: a French multicenter double blind clinical study]J P Castaigne
La Revue Du Praticien|April 1, 1978
[Physicians and smoking]C Boutin, J P Castaigne
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Pancrease gastroresistance: in vitro evaluation of pH-determined dissolutionC Lenaerts, N Beraud, J P Castaigne
American Journal of Hematology|February 1, 1985
Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitroM Sablayrolles, H Wajcman, J P Castaigne, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|December 1, 1986
[Clinical and biological justifications for the use of Triella]J L McGuire, S A Pasquale, J P Castaigne
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosisJ P Chazalette, M P Dain, J P Castaigne
Haematologia|January 1, 1984
In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregantM Sablayrolles, H Wajcman, J P Castaigne, et al.
Lancet (London, England)|February 20, 1988
Addition of desmopressin to recombinant human erythropoietin in treatment of haemostatic defect of uraemiaC Jacquot, J P Masselot, J M Berthelot, et al.
Agents and Actions. Supplements|January 1, 1984
Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crisesR Cabannes, J Lonsdorfer, J P Castaigne, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|September 21, 1990
[Therapeutical trials in arterial hypertension in 1990]J P Castaigne
Contraception, Fertilite, Sexualite|January 1, 1985
[Triella: a French multicenter double blind clinical study]J P Castaigne
La Revue Du Praticien|April 1, 1978
[Physicians and smoking]C Boutin, J P Castaigne
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Pancrease gastroresistance: in vitro evaluation of pH-determined dissolutionC Lenaerts, N Beraud, J P Castaigne
American Journal of Hematology|February 1, 1985
Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitroM Sablayrolles, H Wajcman, J P Castaigne, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|December 1, 1986
[Clinical and biological justifications for the use of Triella]J L McGuire, S A Pasquale, J P Castaigne
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosisJ P Chazalette, M P Dain, J P Castaigne
Haematologia|January 1, 1984
In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregantM Sablayrolles, H Wajcman, J P Castaigne, et al.
Lancet (London, England)|February 20, 1988
Addition of desmopressin to recombinant human erythropoietin in treatment of haemostatic defect of uraemiaC Jacquot, J P Masselot, J M Berthelot, et al.
Agents and Actions. Supplements|January 1, 1984
Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crisesR Cabannes, J Lonsdorfer, J P Castaigne, et al.
Pageof 2